Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Adenoma, Pleomorphic × Clear all

Phase

Status

Withdrawn 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 436 Neoplasms 317 Carcinoma, Non-Small-Cell Lung 250 Prostatic Neoplasms 234 Lung Neoplasms 173 Colorectal Neoplasms 156 Pancreatic Neoplasms 147 Neoplasm Metastasis 142 Leukemia, Myeloid, Acute 138 Multiple Myeloma 128 Carcinoma, Hepatocellular 127 Lymphoma 126 Ovarian Neoplasms 108 Melanoma 108 Brain Neoplasms 100 Head and Neck Neoplasms 99 Recurrence 98 Leukemia, Lymphocytic, Chronic, B-Cell 96 Leukemia 96 Precursor Cell Lymphoblastic Leukemia-Lymphoma 87 Glioblastoma 84 Lymphoma, Non-Hodgkin 83 Colonic Neoplasms 78 Squamous Cell Carcinoma of Head and Neck 76 Lymphoma, Follicular 75 Carcinoma, Renal Cell 73 Lymphoma, Large B-Cell, Diffuse 71 Hematologic Neoplasms 69 Sarcoma 60 Stomach Neoplasms 58

Interventions

Radiation 1 Panitumumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00984217 2016-01-08

Trial of Radiotherapy and Panitumumab in Salivary Gland Malignancies

University of Pittsburgh

Phase 2 Withdrawn

Adenoma, Pleomorphic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡